Nephro Care India Limited (NSE:NEPHROCARE)
India · Delayed Price · Currency is INR 68.85
+0.80 (1.18%)
At close: Jun 17, 2026
Nephro Care India Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 887.35 | 460.31 | 272.31 | 170.93 | 34.24 |
Other Revenue | 15.48 | - | -0 | - | - |
| 902.82 | 460.31 | 272.31 | 170.93 | 34.24 | |
Revenue Growth (YoY) | 96.13% | 69.04% | 59.31% | 399.14% | 87.66% |
Cost of Revenue | 412.1 | 209.12 | 114.39 | 62.29 | 18.7 |
Gross Profit | 490.72 | 251.19 | 157.91 | 108.64 | 15.55 |
Selling, General & Admin | - | 28.96 | 12.58 | 9.51 | 3.87 |
Other Operating Expenses | 392.03 | 160.65 | 79.68 | 64.87 | 10.42 |
Operating Expenses | 442.77 | 214.21 | 97.53 | 82.23 | 15.41 |
Operating Income | 47.95 | 36.98 | 60.38 | 26.41 | 0.14 |
Interest Expense | -1.57 | -0.13 | -0.04 | -0.08 | -0.15 |
Interest & Investment Income | - | 1.56 | 0.01 | 0.01 | 0.02 |
Other Non Operating Income (Expenses) | -0 | -0.92 | -0.73 | -0.57 | -0.02 |
EBT Excluding Unusual Items | 46.38 | 37.49 | 59.63 | 25.77 | 0 |
Gain (Loss) on Sale of Investments | - | 10.8 | 2.61 | - | - |
Other Unusual Items | - | - | -0.91 | - | - |
Pretax Income | 46.38 | 48.29 | 61.32 | 25.77 | 0 |
Income Tax Expense | 12.69 | 11.9 | 17.21 | 2.05 | 0.1 |
Net Income | 33.69 | 36.39 | 44.11 | 23.73 | -0.1 |
Net Income to Common | 33.69 | 36.39 | 44.11 | 23.73 | -0.1 |
Net Income Growth | -7.42% | -17.51% | 85.94% | - | - |
Shares Outstanding (Basic) | 17 | 15 | 12 | 10 | 4 |
Shares Outstanding (Diluted) | 17 | 15 | 12 | 10 | 4 |
Shares Change (YoY) | 8.07% | 29.10% | 18.36% | 181.20% | 1678.08% |
EPS (Basic) | 2.04 | 2.38 | 3.73 | 2.37 | -0.03 |
EPS (Diluted) | 2.04 | 2.38 | 3.73 | 2.37 | -0.03 |
EPS Growth | -14.29% | -36.14% | 57.26% | - | - |
Free Cash Flow | -55.96 | -219.79 | -23.78 | 36.17 | -22.75 |
Free Cash Flow Per Share | -3.39 | -14.38 | -2.01 | 3.62 | -6.40 |
Gross Margin | 54.35% | 54.57% | 57.99% | 63.56% | 45.40% |
Operating Margin | 5.31% | 8.03% | 22.17% | 15.45% | 0.41% |
Profit Margin | 3.73% | 7.90% | 16.20% | 13.88% | -0.29% |
Free Cash Flow Margin | -6.20% | -47.75% | -8.73% | 21.16% | -66.44% |
EBITDA | 98.69 | 61.58 | 65.66 | 34.25 | 1.26 |
EBITDA Margin | 10.93% | 13.38% | 24.11% | 20.04% | 3.67% |
D&A For EBITDA | 50.74 | 24.6 | 5.28 | 7.84 | 1.11 |
EBIT | 47.95 | 36.98 | 60.38 | 26.41 | 0.14 |
EBIT Margin | 5.31% | 8.03% | 22.17% | 15.45% | 0.41% |
Effective Tax Rate | 27.37% | 24.65% | 28.06% | 7.94% | 5000.00% |
Revenue as Reported | 902.82 | 475.58 | 276.01 | 170.95 | 34.27 |
Advertising Expenses | - | 5.22 | 1.88 | 0.84 | 0.07 |